Life Sciences Partners 7
LSP · adviser of record: LSP Advisory BV · 2021 vintage
Life Sciences Partners 7 is a 2021 venture fund managed by LSP, with $688mm raised (Form D, amount sold). It reported $628mm in gross assets at year-end 2025, 0.91x its size, its highest reported value.
- Latest value held
- $628mm year-end 2025
- Peak
- $628mm year-end 2025
- Fund size
- $688mm Form D, amount sold
- Held vs. size
- 0.91x peak 0.91x
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2025 | $628mm | 0.91x | +183% over 2 yrs |
| 2023 | $222mm | 0.32x | +112% |
| 2022 | $104mm | 0.15x | +16% |
| 2021 | $90.1mm | 0.13x | – |
Other funds from LSP
- LSP Health Economics Fund 2 2022
- LSP Health Economics Fund 2022
- LSP Dementia Fund 2020
- Life Sciences Partners 6 CV 2017
- Life Sciences Partners V CV 2014
- LSP Health Economics Fund B CV 2014
- LSP Health Economics Fund CV 2011
- Life Sciences Partners IV BV 2011
- Life Sciences Partners IV CV 2011
- Life Sciences Partners III BV 2011
- LSP Bioventures CV 2011
- Life Sciences Partners II BV 2011
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-2089142628. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.